127 related articles for article (PubMed ID: 20884073)
1. The impotence of price controls: failed attempts to constrain pharmaceutical expenditures in Greece.
Lambrelli D; O'Donnell O
Health Policy; 2011 Jul; 101(2):162-71. PubMed ID: 20884073
[TBL] [Abstract][Full Text] [Related]
2. Spending on medicines in Israel in an international context.
Sax P
Isr Med Assoc J; 2005 May; 7(5):286-91. PubMed ID: 15909459
[TBL] [Abstract][Full Text] [Related]
3. Pattern of statins' utilization at Ramathobodi Hospital, 2005 to 2007.
Pattanaprateep O; Pongcharoensuk P; Suvanakoot P; Kaojarern S
J Med Assoc Thai; 2010 Oct; 93(10):1223-31. PubMed ID: 20973328
[TBL] [Abstract][Full Text] [Related]
4. Pharmaceutical management in ProCare Health Limited.
Malcolm L; Barry M; MacLean I
N Z Med J; 2001 Jun; 114(1134):283-6. PubMed ID: 11480510
[TBL] [Abstract][Full Text] [Related]
5. Price cuts and drug spending in South Korea: the case of antihyperlipidemic agents.
Kwon HY; Hong JM; Godman B; Yang BM
Health Policy; 2013 Oct; 112(3):217-26. PubMed ID: 24075008
[TBL] [Abstract][Full Text] [Related]
6. [Assessment of the pharmaceutical expenditure in Hungary].
Inotai A; Merész G; Kaló Z
Acta Pharm Hung; 2010; 80(4):162-72. PubMed ID: 21404477
[TBL] [Abstract][Full Text] [Related]
7. Comparative approaches to pharmaceutical price regulation in the European Union.
Mrazek MF
Croat Med J; 2002 Aug; 43(4):453-61. PubMed ID: 12187524
[TBL] [Abstract][Full Text] [Related]
8. Trends in prescribing in primary care in Croatia, 2000-2012: prescribing volume, costs and regulatory measures.
Vojvodić Z; Nelken-Bestvina D; Kurc-Bionda A; Stimac D
Coll Antropol; 2014 Dec; 38 Suppl 2():67-72. PubMed ID: 25643530
[TBL] [Abstract][Full Text] [Related]
9. The impact of China's retail drug price control policy on hospital expenditures: a case study in two Shandong hospitals.
Meng Q; Cheng G; Silver L; Sun X; Rehnberg C; Tomson G
Health Policy Plan; 2005 May; 20(3):185-96. PubMed ID: 15840634
[TBL] [Abstract][Full Text] [Related]
10. The power of r - pharmaceutical sales decomposition in Cyprus public healthcare sector and determinants of drug expenditure evolution: any lessons learned?
Petrou P
Expert Rev Pharmacoecon Outcomes Res; 2014 Apr; 14(2):289-300. PubMed ID: 24580120
[TBL] [Abstract][Full Text] [Related]
11. The effect of newer drugs on health spending: do they really increase the costs?
Civan A; Köksal B
Health Econ; 2010 May; 19(5):581-95. PubMed ID: 19404925
[TBL] [Abstract][Full Text] [Related]
12. Seniors' prescription drug cost inflation and cost containment: evidence from British Columbia.
Morgan SG; Agnew JD; Barer ML
Health Policy; 2004 Jun; 68(3):299-307. PubMed ID: 15113641
[TBL] [Abstract][Full Text] [Related]
13. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly.
Liu SZ; Romeis JC
Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666
[TBL] [Abstract][Full Text] [Related]
14. [Rising costs of drugs in hospitals in the period 1996-2000 and over the next few years].
Breekveldt-Postma NS; Zwart-van Rijkom JE; Egberts AC; Leufkens HG; Herings RM
Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2547-51. PubMed ID: 12532669
[TBL] [Abstract][Full Text] [Related]
15. Pharmaceutical pricing and reimbursement reforms in Greece.
Yfantopoulos J
Eur J Health Econ; 2008 Feb; 9(1):87-97. PubMed ID: 17619920
[TBL] [Abstract][Full Text] [Related]
16. Impact of a generic substitution reform on patients' and society's expenditure for pharmaceuticals.
Andersson K; Bergström G; Petzold MG; Carlsten A
Health Policy; 2007 May; 81(2-3):376-84. PubMed ID: 16945449
[TBL] [Abstract][Full Text] [Related]
17. Direct costs for the treatment of HIV-infection in a German cohort after the introduction of HAART.
Stoll M; Claes C; Schulte E; Graf von der Schulenburg JM; Schmidt RE
Eur J Med Res; 2002 Nov; 7(11):463-71. PubMed ID: 12568973
[TBL] [Abstract][Full Text] [Related]
18. International variation in prescribing antihypertensive drugs: its extent and possible explanations.
Fretheim A; Oxman AD
BMC Health Serv Res; 2005 Mar; 5(1):21. PubMed ID: 15762983
[TBL] [Abstract][Full Text] [Related]
19. Trends and determinants of prescription drug expenditures in the elderly: data from the British Columbia Pharmacare Program.
Anderson GM; Kerluke KJ; Pulcins IR; Hertzman C; Barer ML
Inquiry; 1993; 30(2):199-207. PubMed ID: 8314608
[TBL] [Abstract][Full Text] [Related]
20. [Drug expenditures of pensioners in 1997-2000].
Swistak P; Błońska-Fajfrowska B
Wiad Lek; 2003; 56(1-2):85-8. PubMed ID: 12901276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]